NovaBay Pharmaceuticals, Inc. (NBY) - Analysis

3.085 USD

0.285

10.18%

Last update Dec 15, 1:33 PM EST

Main market

Day range

3.085

2.735

3.2

Previous close

2.80000

Open

2.735

Access this stock data via API

NovaBay Pharmaceuticals, Inc.

3.09

0.29

10.18%

Analysis

Revenue estimate	Current year (Dec 2025)	Next year (Dec 2026)
Number of Analysts	0	0
Avg. estimate	0	0
Low estimate	0	0
High estimate	0	0
Last year sales	—	—
Sales growth	—	—

Access /revenue_estimate data via our API — starting from the Ultra plan.

EPS revisions	Current year (Dec 2025)	Next year (Dec 2026)
Up last 7 days	0	0
Up last 30 days	0	0
Down last 7 days	0	0
Down last 30 days	0	0

Access /eps_revisions data via our API — starting from the Ultra plan.

Analyst ratings

Firm	Date	Action
Ascendiant Capital	Nov 11, 2024	Maintains
Ladenburg Thalmann	Aug 11, 2023	Maintains
Ladenburg Thalmann	Sep 18, 2019	Initiates
H.C. Wainwright	Mar 13, 2019	Downgrade
Roth Capital	Mar 26, 2018	Downgrade
Roth Capital	Jun 05, 2017	Initiates
Maxim Group	Mar 07, 2016	Downgrade
Maxim Group	Apr 30, 2015	Initiates
Ascendiant Capital	Mar 06, 2013	Initiates
Ascendiant Capital	Mar 05, 2013	Initiates

Access /analyst_ratings/light data via our API — starting from the Ultra plan.